← FDA Drug Approvals (Drugs@FDA)

ENALAPRIL MALEATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2022-06-29

Drug application

FDA Application #

ANDA212894

Application type

Abbreviated New Drug Application (Generic)

Brand name

ENALAPRIL MALEATE

Generic name

ENALAPRIL

Active ingredients

ENALAPRIL MALEATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

AMNEAL

Manufacturer

Amneal Pharmaceuticals NY LLC

First approval

2022-06-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown